Click here to get full coverage on ANAPTYSBIO, INC ($ANAB) CEO 2025 Pay Revealed - Quiver Quantitative

ANAPTYSBIO, INC ($ANAB) CEO 2025 Pay Revealed  Quiver Quantitative

ANAPTYSBIO, INC ($ANAB) CEO 2025 Pay Revealed - Quiver Quantitative

Click here to get full coverage on Enterprise value to EBITDA forward of AnaptysBio, Inc. – NASDAQ:ANAB - TradingView

Enterprise value to EBITDA forward of AnaptysBio, Inc. – NASDAQ:ANAB  TradingView

Enterprise value to EBITDA forward of AnaptysBio, Inc. – NASDAQ:ANAB - TradingView

Click here to get full coverage on ISO/IEC 17021-1:2015—Requirements for Certification Bodies - American National Standards Institute - ANSI

ISO/IEC 17021-1:2015—Requirements for Certification Bodies  American National Standards Institute - ANSI

ISO/IEC 17021-1:2015—Requirements for Certification Bodies - American National Standards Institute - ANSI

Click here to get full coverage on Affiliate plans to sell 9,476 ANAB shares (NASDAQ: ANAB) - Stock Titan

Affiliate plans to sell 9,476 ANAB shares (NASDAQ: ANAB)  Stock Titan

Affiliate plans to sell 9,476 ANAB shares (NASDAQ: ANAB) - Stock Titan

Click here to get full coverage on ANAB News | ANAPTYSBIO INC (NASDAQ:ANAB) - ChartMill

ANAB News | ANAPTYSBIO INC (NASDAQ:ANAB)  ChartMill

ANAB News | ANAPTYSBIO INC (NASDAQ:ANAB) - ChartMill

Click here to get full coverage on AnaptysBio, Inc.(NasdaqGS: ANAB) dropped from Russell 3000E Index - marketscreener.com

AnaptysBio, Inc.(NasdaqGS: ANAB) dropped from Russell 3000E Index  marketscreener.com

AnaptysBio, Inc.(NasdaqGS: ANAB) dropped from Russell 3000E Index - marketscreener.com

Click here to get full coverage on AnaptysBio (ANAB) Draws Valuation Attention, Is The Market Already Pricing In Future Growth? - Sahm

AnaptysBio (ANAB) Draws Valuation Attention, Is The Market Already Pricing In Future Growth?  Sahm

AnaptysBio (ANAB) Draws Valuation Attention, Is The Market Already Pricing In Future Growth? - Sahm

Click here to get full coverage on AnaptysBio (NASDAQ: ANAB) proxy details director votes and equity plan limits - Stock Titan

AnaptysBio (NASDAQ: ANAB) proxy details director votes and equity plan limits  Stock Titan

AnaptysBio (NASDAQ: ANAB) proxy details director votes and equity plan limits - Stock Titan

Click here to get full coverage on AnaptysBio (ANAB) Surges 14.8%: Is This an Indication of Further Gains? - Yahoo Finance

AnaptysBio (ANAB) Surges 14.8%: Is This an Indication of Further Gains?  Yahoo Finance

AnaptysBio (ANAB) Surges 14.8%: Is This an Indication of Further Gains? - Yahoo Finance

Click here to get full coverage on Accreditation and Sustainability (Part 3 of 3) - American National Standards Institute - ANSI

Accreditation and Sustainability (Part 3 of 3)  American National Standards Institute - ANSI

Accreditation and Sustainability (Part 3 of 3) - American National Standards Institute - ANSI

Click here to get full coverage on AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance

AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now  Yahoo Finance

AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance

Click here to get full coverage on ANAB (NASDAQ) insider sells 10,000 shares; Mulroy made multiple May–June sales - Stock Titan

ANAB (NASDAQ) insider sells 10,000 shares; Mulroy made multiple May–June sales  Stock Titan

ANAB (NASDAQ) insider sells 10,000 shares; Mulroy made multiple May–June sales - Stock Titan

Click here to get full coverage on AnaptysBio, Inc.(NasdaqGS: ANAB) dropped from Russell Microcap Index - marketscreener.com

AnaptysBio, Inc.(NasdaqGS: ANAB) dropped from Russell Microcap Index  marketscreener.com

AnaptysBio, Inc.(NasdaqGS: ANAB) dropped from Russell Microcap Index - marketscreener.com

Click here to get full coverage on ISO 14001:2026 Transition | Key Changes and How to Prepare - American National Standards Institute - ANSI

ISO 14001:2026 Transition | Key Changes and How to Prepare  American National Standards Institute - ANSI

ISO 14001:2026 Transition | Key Changes and How to Prepare - American National Standards Institute - ANSI

Click here to get full coverage on Outcomes-Based Cybersecurity Training: Why Accreditation Matters - American National Standards Institute - ANSI

Outcomes-Based Cybersecurity Training: Why Accreditation Matters  American National Standards Institute - ANSI

Outcomes-Based Cybersecurity Training: Why Accreditation Matters - American National Standards Institute - ANSI

Click here to get full coverage on Accreditation and Innovation (Part 1 of 3) - American National Standards Institute - ANSI

Accreditation and Innovation (Part 1 of 3)  American National Standards Institute - ANSI

Accreditation and Innovation (Part 1 of 3) - American National Standards Institute - ANSI

Click here to get full coverage on Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?  Yahoo Finance

Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Click here to get full coverage on AnaptysBio, Inc. (ANAB) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

AnaptysBio, Inc. (ANAB) is a Great Momentum Stock: Should You Buy?  Yahoo Finance

AnaptysBio, Inc. (ANAB) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Click here to get full coverage on Transformational Change in 529 Plans: What This Means for ANAB Accredited Programs - American National Standards Institute - ANSI

Transformational Change in 529 Plans: What This Means for ANAB Accredited Programs  American National Standards Institute - ANSI

Transformational Change in 529 Plans: What This Means for ANAB Accredited Programs - American National Standards Institute - ANSI

Click here to get full coverage on Assessing AnaptysBio (ANAB) Valuation After Royalty Pivot Spinoff And Legal Outcome - Yahoo Finance

Assessing AnaptysBio (ANAB) Valuation After Royalty Pivot Spinoff And Legal Outcome  Yahoo Finance

Assessing AnaptysBio (ANAB) Valuation After Royalty Pivot Spinoff And Legal Outcome - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $ANAB Given $95 Price Target - Quiver Quantitative

New Analyst Forecast: $ANAB Given $95 Price Target  Quiver Quantitative

New Analyst Forecast: $ANAB Given $95 Price Target - Quiver Quantitative

Click here to get full coverage on 2026 Revision of ISO/IEC 17020: What Changes Are Coming and How ANAB Is Preparing Inspection Bodies - American National Standards Institute - ANSI

2026 Revision of ISO/IEC 17020: What Changes Are Coming and How ANAB Is Preparing Inspection Bodies  American National Standards Institute - ANSI

2026 Revision of ISO/IEC 17020: What Changes Are Coming and How ANAB Is Preparing Inspection Bodies - American National Standards Institute - ANSI

Click here to get full coverage on Assessing AnaptysBio (ANAB) Valuation After New US$100 Million Buyback And Cancelled Equity Offerings - Yahoo Finance

Assessing AnaptysBio (ANAB) Valuation After New US$100 Million Buyback And Cancelled Equity Offerings  Yahoo Finance

Assessing AnaptysBio (ANAB) Valuation After New US$100 Million Buyback And Cancelled Equity Offerings - Yahoo Finance

Click here to get full coverage on AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release  Yahoo Finance

AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

Click here to get full coverage on AnaptysBio (ANAB) Stock Could Be 84% Below Fair Value After Choppy Trading - simplywall.st

AnaptysBio (ANAB) Stock Could Be 84% Below Fair Value After Choppy Trading  simplywall.st

AnaptysBio (ANAB) Stock Could Be 84% Below Fair Value After Choppy Trading - simplywall.st

Click here to get full coverage on AnaptysBio, Inc. (ANAB) Q4 Earnings and Revenues Top Estimates - Yahoo Finance

AnaptysBio, Inc. (ANAB) Q4 Earnings and Revenues Top Estimates  Yahoo Finance

AnaptysBio, Inc. (ANAB) Q4 Earnings and Revenues Top Estimates - Yahoo Finance

Click here to get full coverage on AnaptysBio (ANAB) Is Up 13.4% After Court Upholds Jemperli Royalty Rights In Tesaro Dispute - Yahoo Finance

AnaptysBio (ANAB) Is Up 13.4% After Court Upholds Jemperli Royalty Rights In Tesaro Dispute  Yahoo Finance

AnaptysBio (ANAB) Is Up 13.4% After Court Upholds Jemperli Royalty Rights In Tesaro Dispute - Yahoo Finance

Click here to get full coverage on Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026? - Yahoo Finance

Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?  Yahoo Finance

Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026? - Yahoo Finance

Click here to get full coverage on How NIST AI Framework Can be Used for ISO/IEC 17024 Compliance - American National Standards Institute - ANSI

How NIST AI Framework Can be Used for ISO/IEC 17024 Compliance  American National Standards Institute - ANSI

How NIST AI Framework Can be Used for ISO/IEC 17024 Compliance - American National Standards Institute - ANSI

Click here to get full coverage on Dennis Mulroy sells multiple ANAB shares (NASDAQ: ANAB) across May–June 2026 - Stock Titan

Dennis Mulroy sells multiple ANAB shares (NASDAQ: ANAB) across May–June 2026  Stock Titan

Dennis Mulroy sells multiple ANAB shares (NASDAQ: ANAB) across May–June 2026 - Stock Titan

Click here to get full coverage on AI Adoption in Conformity Assessment - American National Standards Institute - ANSI

AI Adoption in Conformity Assessment  American National Standards Institute - ANSI

AI Adoption in Conformity Assessment - American National Standards Institute - ANSI

Click here to get full coverage on ANAB (NASDAQ: ANAB) affiliate files Form 144 to sell 20,000 shares - Stock Titan

ANAB (NASDAQ: ANAB) affiliate files Form 144 to sell 20,000 shares  Stock Titan

ANAB (NASDAQ: ANAB) affiliate files Form 144 to sell 20,000 shares - Stock Titan

Click here to get full coverage on $ANAB stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

$ANAB stock is up 8% today. Here's what we see in our data.  Quiver Quantitative

$ANAB stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Is AnaptysBio (ANAB) Still Attractively Priced After 242% One-Year Share Price Surge? - Yahoo Finance

Is AnaptysBio (ANAB) Still Attractively Priced After 242% One-Year Share Price Surge?  Yahoo Finance

Is AnaptysBio (ANAB) Still Attractively Priced After 242% One-Year Share Price Surge? - Yahoo Finance

Click here to get full coverage on 850-share sale notice by insider at ANAB (NASDAQ: ANAB) via Form 144 - Stock Titan

850-share sale notice by insider at ANAB (NASDAQ: ANAB) via Form 144  Stock Titan

850-share sale notice by insider at ANAB (NASDAQ: ANAB) via Form 144 - Stock Titan

Click here to get full coverage on AnaptysBio, Inc. $ANAB Shares Purchased by 683 Capital Management LLC - MarketBeat

AnaptysBio, Inc. $ANAB Shares Purchased by 683 Capital Management LLC  MarketBeat

AnaptysBio, Inc. $ANAB Shares Purchased by 683 Capital Management LLC - MarketBeat

Click here to get full coverage on First Tracks targets $180M cash at launch after $145M financing - Stock Titan

First Tracks targets $180M cash at launch after $145M financing  Stock Titan

First Tracks targets $180M cash at launch after $145M financing - Stock Titan

Click here to get full coverage on Are Medical Stocks Lagging AnaptysBio (ANAB) This Year? - Yahoo Finance

Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?  Yahoo Finance

Are Medical Stocks Lagging AnaptysBio (ANAB) This Year? - Yahoo Finance

Click here to get full coverage on AnaptysBio (ANAB) director acquires 6,030 shares via RSU vesting - Stock Titan

AnaptysBio (ANAB) director acquires 6,030 shares via RSU vesting  Stock Titan

AnaptysBio (ANAB) director acquires 6,030 shares via RSU vesting - Stock Titan

Click here to get full coverage on AnaptysBio (NASDAQ: ANAB) subleases San Diego facility to First Tracks under master lease - Stock Titan

AnaptysBio (NASDAQ: ANAB) subleases San Diego facility to First Tracks under master lease  Stock Titan

AnaptysBio (NASDAQ: ANAB) subleases San Diego facility to First Tracks under master lease - Stock Titan

Click here to get full coverage on ANAB (NASDAQ: ANAB) affiliate files Form 144 listing multiple share dispositions - Stock Titan

ANAB (NASDAQ: ANAB) affiliate files Form 144 listing multiple share dispositions  Stock Titan

ANAB (NASDAQ: ANAB) affiliate files Form 144 listing multiple share dispositions - Stock Titan

Click here to get full coverage on Director at AnaptysBio (NASDAQ: ANAB) receives 6,030 shares via RSUs - Stock Titan

Director at AnaptysBio (NASDAQ: ANAB) receives 6,030 shares via RSUs  Stock Titan

Director at AnaptysBio (NASDAQ: ANAB) receives 6,030 shares via RSUs - Stock Titan

Click here to get full coverage on Director John Orwin of ANAPTYSBIO (NASDAQ: ANAB) settles 6,030 RSUs into common stock - Stock Titan

Director John Orwin of ANAPTYSBIO (NASDAQ: ANAB) settles 6,030 RSUs into common stock  Stock Titan

Director John Orwin of ANAPTYSBIO (NASDAQ: ANAB) settles 6,030 RSUs into common stock - Stock Titan

Click here to get full coverage on Measuring What Matters: The Future of Certifications - American National Standards Institute - ANSI

Measuring What Matters: The Future of Certifications  American National Standards Institute - ANSI

Measuring What Matters: The Future of Certifications - American National Standards Institute - ANSI

Click here to get full coverage on Eversept Partners LP Takes $5.86 Million Position in AnaptysBio, Inc. $ANAB - MarketBeat

Eversept Partners LP Takes $5.86 Million Position in AnaptysBio, Inc. $ANAB  MarketBeat

Eversept Partners LP Takes $5.86 Million Position in AnaptysBio, Inc. $ANAB - MarketBeat

Click here to get full coverage on ANAB (ANAB) insider files Form 144 to sell 20,000 shares via option exercise - Stock Titan

ANAB (ANAB) insider files Form 144 to sell 20,000 shares via option exercise  Stock Titan

ANAB (ANAB) insider files Form 144 to sell 20,000 shares via option exercise - Stock Titan

Click here to get full coverage on Granahan Investment Management LLC Reduces Holdings in AnaptysBio, Inc. $ANAB - MarketBeat

Granahan Investment Management LLC Reduces Holdings in AnaptysBio, Inc. $ANAB  MarketBeat

Granahan Investment Management LLC Reduces Holdings in AnaptysBio, Inc. $ANAB - MarketBeat

Click here to get full coverage on After spin-off, Anaptys shifts to royalty-only model with $140M-$145M cash - Stock Titan

After spin-off, Anaptys shifts to royalty-only model with $140M-$145M cash  Stock Titan

After spin-off, Anaptys shifts to royalty-only model with $140M-$145M cash - Stock Titan

Click here to get full coverage on Sofinnova Investments Inc. Has $13.95 Million Stock Position in AnaptysBio, Inc. $ANAB - MarketBeat

Sofinnova Investments Inc. Has $13.95 Million Stock Position in AnaptysBio, Inc. $ANAB  MarketBeat

Sofinnova Investments Inc. Has $13.95 Million Stock Position in AnaptysBio, Inc. $ANAB - MarketBeat

Click here to get full coverage on Insider Sale: President of $ANAB Sells 3,155 Shares - Quiver Quantitative

Insider Sale: President of $ANAB Sells 3,155 Shares  Quiver Quantitative

Insider Sale: President of $ANAB Sells 3,155 Shares - Quiver Quantitative

Click here to get full coverage on Insider Sale: CHIEF LEGAL OFFICER of $ANAB Sells 1,841 Shares - Quiver Quantitative

Insider Sale: CHIEF LEGAL OFFICER of $ANAB Sells 1,841 Shares  Quiver Quantitative

Insider Sale: CHIEF LEGAL OFFICER of $ANAB Sells 1,841 Shares - Quiver Quantitative

Click here to get full coverage on AnaptysBio, Inc. $ANAB Shares Acquired by BNP Paribas Financial Markets - MarketBeat

AnaptysBio, Inc. $ANAB Shares Acquired by BNP Paribas Financial Markets  MarketBeat

AnaptysBio, Inc. $ANAB Shares Acquired by BNP Paribas Financial Markets - MarketBeat

Click here to get full coverage on AnaptysBio rises after completing First Tracks spinoff - Seeking Alpha

AnaptysBio rises after completing First Tracks spinoff  Seeking Alpha

AnaptysBio rises after completing First Tracks spinoff - Seeking Alpha

Click here to get full coverage on ANAB SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus

ANAB SWOT Analysis: Financial Challenges and Growth Potential Re  GuruFocus

ANAB SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus

Click here to get full coverage on After its biotech spin-off, Anaptys plans to buy back $100M in stock - Stock Titan

After its biotech spin-off, Anaptys plans to buy back $100M in stock  Stock Titan

After its biotech spin-off, Anaptys plans to buy back $100M in stock - Stock Titan

Click here to get full coverage on How Do AnaptysBio’s (ANAB) Jemperli Royalties Shape Its Investment Case After Tesaro’s Claim Dismissal? - simplywall.st

How Do AnaptysBio’s (ANAB) Jemperli Royalties Shape Its Investment Case After Tesaro’s Claim Dismissal?  simplywall.st

How Do AnaptysBio’s (ANAB) Jemperli Royalties Shape Its Investment Case After Tesaro’s Claim Dismissal? - simplywall.st

Click here to get full coverage on AnaptysBio, Inc. (NASDAQ:ANAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

AnaptysBio, Inc. (NASDAQ:ANAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages  MarketBeat

AnaptysBio, Inc. (NASDAQ:ANAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Click here to get full coverage on ANAB Stock Falls After Company Sues GSK Unit Tesaro Again, Claims Fresh Breach Of 2014 Deal - Stocktwits

ANAB Stock Falls After Company Sues GSK Unit Tesaro Again, Claims Fresh Breach Of 2014 Deal  Stocktwits

ANAB Stock Falls After Company Sues GSK Unit Tesaro Again, Claims Fresh Breach Of 2014 Deal - Stocktwits

Click here to get full coverage on AnaptysBio Inc. (ANAB) Surges 4.3% as Biotech Sentiment Improves — Key Levels to Watch - Quality Factor - Město Břeclav

AnaptysBio Inc. (ANAB) Surges 4.3% as Biotech Sentiment Improves — Key Levels to Watch - Quality Factor  Město Břeclav

AnaptysBio Inc. (ANAB) Surges 4.3% as Biotech Sentiment Improves — Key Levels to Watch - Quality Factor - Město Břeclav

Click here to get full coverage on AnaptysBio Shifts Fiscal Year-End As Volatile Stock Eyes Growth Forecasts - simplywall.st

AnaptysBio Shifts Fiscal Year-End As Volatile Stock Eyes Growth Forecasts  simplywall.st

AnaptysBio Shifts Fiscal Year-End As Volatile Stock Eyes Growth Forecasts - simplywall.st

Click here to get full coverage on Insider Sale: Chief Medical Officer of $ANAB Sells 3,650 Shares - Quiver Quantitative

Insider Sale: Chief Medical Officer of $ANAB Sells 3,650 Shares  Quiver Quantitative

Insider Sale: Chief Medical Officer of $ANAB Sells 3,650 Shares - Quiver Quantitative

Click here to get full coverage on Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations - Yahoo Finance

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations  Yahoo Finance

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations - Yahoo Finance

Click here to get full coverage on ANAB: Business split, strong JEMPERLI royalties, and key clinical milestones set for 2024 - TradingView

ANAB: Business split, strong JEMPERLI royalties, and key clinical milestones set for 2024  TradingView

ANAB: Business split, strong JEMPERLI royalties, and key clinical milestones set for 2024 - TradingView

Click here to get full coverage on AnaptysBio (ANAB) Shares Rise Following Successful Spinoff of Fi - GuruFocus

AnaptysBio (ANAB) Shares Rise Following Successful Spinoff of Fi  GuruFocus

AnaptysBio (ANAB) Shares Rise Following Successful Spinoff of Fi - GuruFocus

Click here to get full coverage on ANAB proposes sale of 15,000 shares (NASDAQ: ANAB) - Stock Titan

ANAB proposes sale of 15,000 shares (NASDAQ: ANAB)  Stock Titan

ANAB proposes sale of 15,000 shares (NASDAQ: ANAB) - Stock Titan

Click here to get full coverage on AnaptysBio (Nasdaq: ANAB) spins off First Tracks and pivots to royalty model - Stock Titan

AnaptysBio (Nasdaq: ANAB) spins off First Tracks and pivots to royalty model  Stock Titan

AnaptysBio (Nasdaq: ANAB) spins off First Tracks and pivots to royalty model - Stock Titan

Click here to get full coverage on Wall Street Bets Big On ARM, ACN, ANAB: Do Retail Investors Concur? - Stocktwits

Wall Street Bets Big On ARM, ACN, ANAB: Do Retail Investors Concur?  Stocktwits

ANAB

Price Chart

Key Statistics

Technicals

About ANAB

Latest News

ANAPTYSBIO, INC ($ANAB) CEO 2025 Pay Revealed - Quiver Quantitative

Enterprise value to EBITDA forward of AnaptysBio, Inc. – NASDAQ:ANAB - TradingView

ISO/IEC 17021-1:2015—Requirements for Certification Bodies - American National Standards Institute - ANSI

Advanced Charts

Top Gainers

Top Losers